ATE253556T1 - Aminoacylaroylpyrrole für die behandlung des neuropathischen schmerzes - Google Patents
Aminoacylaroylpyrrole für die behandlung des neuropathischen schmerzesInfo
- Publication number
- ATE253556T1 ATE253556T1 AT00911850T AT00911850T ATE253556T1 AT E253556 T1 ATE253556 T1 AT E253556T1 AT 00911850 T AT00911850 T AT 00911850T AT 00911850 T AT00911850 T AT 00911850T AT E253556 T1 ATE253556 T1 AT E253556T1
- Authority
- AT
- Austria
- Prior art keywords
- aminoacylaroylpyrroles
- treatment
- neuropathic pain
- neuropathic
- pain
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D207/00—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom
- C07D207/02—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D207/30—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having two double bonds between ring members or between ring members and non-ring members
- C07D207/32—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having two double bonds between ring members or between ring members and non-ring members with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to ring carbon atoms
- C07D207/33—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having two double bonds between ring members or between ring members and non-ring members with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to ring carbon atoms with substituted hydrocarbon radicals, directly attached to ring carbon atoms
- C07D207/333—Radicals substituted by oxygen or sulfur atoms
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/02—Drugs for disorders of the nervous system for peripheral neuropathies
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/04—Centrally acting analgesics, e.g. opioids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D207/00—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom
- C07D207/02—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D207/30—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having two double bonds between ring members or between ring members and non-ring members
- C07D207/32—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having two double bonds between ring members or between ring members and non-ring members with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to ring carbon atoms
- C07D207/33—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having two double bonds between ring members or between ring members and non-ring members with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to ring carbon atoms with substituted hydrocarbon radicals, directly attached to ring carbon atoms
- C07D207/335—Radicals substituted by nitrogen atoms not forming part of a nitro radical
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
- C07D401/06—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US12047799P | 1999-02-18 | 1999-02-18 | |
PCT/US2000/004063 WO2000048584A2 (en) | 1999-02-18 | 2000-02-17 | Aroyl aminoacyl pyrroles for use in the treatment of neuropathic pain |
Publications (1)
Publication Number | Publication Date |
---|---|
ATE253556T1 true ATE253556T1 (de) | 2003-11-15 |
Family
ID=22390558
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
AT00911850T ATE253556T1 (de) | 1999-02-18 | 2000-02-17 | Aminoacylaroylpyrrole für die behandlung des neuropathischen schmerzes |
Country Status (14)
Country | Link |
---|---|
US (2) | US6191142B1 (de) |
EP (1) | EP1154996B1 (de) |
JP (1) | JP2002537247A (de) |
AR (1) | AR022620A1 (de) |
AT (1) | ATE253556T1 (de) |
AU (1) | AU3367500A (de) |
CA (1) | CA2361390A1 (de) |
DE (1) | DE60006363T2 (de) |
DK (1) | DK1154996T3 (de) |
ES (1) | ES2209843T3 (de) |
HK (1) | HK1041003B (de) |
TR (1) | TR200103219T2 (de) |
TW (1) | TW562797B (de) |
WO (1) | WO2000048584A2 (de) |
Families Citing this family (6)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2002002521A2 (en) * | 2000-06-30 | 2002-01-10 | Ortho-Mcneil Pharmaceutical, Inc. | Aroyl aminoacyl pyrrole compounds and their pharmaceutical use |
US6492387B2 (en) | 2000-12-20 | 2002-12-10 | Ortho-Mcneil Pharamaceutical, Inc. | Isoindolyl and isoquinolinyl aroyl pyrrole compounds |
US6897319B2 (en) * | 2001-12-27 | 2005-05-24 | Ortho-Mcneil Pharmaceutical, Inc. | Useful aroyl pyrrole heteroaryl methanones and methanols |
WO2003066040A1 (fr) | 2002-02-05 | 2003-08-14 | Ajinomoto Co.,Inc. | Compositions medicinales contenant une gabapentine ou une pregabaline et antagoniste a canal de calcium de type n |
HU230403B1 (hu) * | 2003-12-19 | 2016-04-28 | Pál Kocsis | Nátrium csatorna blokkoló és szerotonin újrafelvétel gátló tartalmú gyógyszerkészítmény |
EP2256103A1 (de) | 2009-05-07 | 2010-12-01 | Biosynth AG | Neue Anzeigerplattform |
Family Cites Families (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5332736A (en) | 1993-11-01 | 1994-07-26 | Ortho Pharmaceutical Corporation | Anti-convulsant aroyl aminoacylpyrroles |
US5418236A (en) | 1993-12-23 | 1995-05-23 | Ortho Pharmaceutical Corporation | Anxiolytic aroyl piperidinyl and piperazinylacyl pyrroles |
AU4078897A (en) * | 1996-08-23 | 1998-03-06 | Algos Pharmaceutical Corporation | Anticonvulsant containing composition for treating neuropathic pain |
US5760007A (en) | 1997-07-16 | 1998-06-02 | Ortho Pharmaceutical Corporation | Anticonvulsant derivatives useful in treating neuropathic pain |
-
2000
- 2000-02-17 US US09/505,916 patent/US6191142B1/en not_active Expired - Lifetime
- 2000-02-17 WO PCT/US2000/004063 patent/WO2000048584A2/en active IP Right Grant
- 2000-02-17 DE DE60006363T patent/DE60006363T2/de not_active Expired - Lifetime
- 2000-02-17 TR TR2001/03219T patent/TR200103219T2/xx unknown
- 2000-02-17 DK DK00911850T patent/DK1154996T3/da active
- 2000-02-17 ES ES00911850T patent/ES2209843T3/es not_active Expired - Lifetime
- 2000-02-17 AR ARP000100674A patent/AR022620A1/es unknown
- 2000-02-17 CA CA002361390A patent/CA2361390A1/en not_active Abandoned
- 2000-02-17 AT AT00911850T patent/ATE253556T1/de active
- 2000-02-17 EP EP00911850A patent/EP1154996B1/de not_active Expired - Lifetime
- 2000-02-17 AU AU33675/00A patent/AU3367500A/en not_active Abandoned
- 2000-02-17 JP JP2000599376A patent/JP2002537247A/ja active Pending
- 2000-03-23 TW TW089102769A patent/TW562797B/zh not_active IP Right Cessation
-
2001
- 2001-02-05 US US09/777,087 patent/US6369228B2/en not_active Expired - Lifetime
-
2002
- 2002-04-18 HK HK02102939.8A patent/HK1041003B/zh unknown
Also Published As
Publication number | Publication date |
---|---|
HK1041003B (zh) | 2004-05-07 |
WO2000048584A2 (en) | 2000-08-24 |
HK1041003A1 (en) | 2002-06-28 |
AU3367500A (en) | 2000-09-04 |
US20010044452A1 (en) | 2001-11-22 |
US6191142B1 (en) | 2001-02-20 |
AR022620A1 (es) | 2002-09-04 |
TW562797B (en) | 2003-11-21 |
ES2209843T3 (es) | 2004-07-01 |
EP1154996A2 (de) | 2001-11-21 |
WO2000048584A3 (en) | 2000-12-07 |
TR200103219T2 (tr) | 2002-04-22 |
JP2002537247A (ja) | 2002-11-05 |
DE60006363T2 (de) | 2005-07-21 |
DE60006363D1 (de) | 2003-12-11 |
EP1154996B1 (de) | 2003-11-05 |
DK1154996T3 (da) | 2004-02-16 |
CA2361390A1 (en) | 2000-08-24 |
US6369228B2 (en) | 2002-04-09 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
DE69927823D1 (de) | Hydrogel für die therapeutische behandlung von aneurysmas | |
DE60124576D1 (de) | Verbindungen verwendbar für die behandlung von entzündungskrankheiten | |
DE60218493D1 (de) | Substituierte 7-aza-ä2.2.1übicycloheptane für die behandlung von krankheiten | |
DE60024649D1 (de) | Verbindungen für die behandlung von ischämie | |
DE60233414D1 (de) | Kombinationen für die behandlung entzündlicher erkrankungen | |
DE50009504D1 (de) | Verwendung von retigabin zur behandlung von neuropathischen schmerzen | |
DE60316538D1 (de) | Dihydrobenzodiazepin-2-on-derivative für die behandlung von neurologischen erkrankungen | |
ATE288431T1 (de) | Substituierte bizyklische derivate für die behandlung von unnormalem zellwachstum | |
ATE551340T1 (de) | Azabicyclisch- substituierte annelierte heteroaryl-verbinungen für die behandlung von krankheiten | |
DE60329123D1 (de) | Benzoädüazepinderivate für die behandlung von neurologischen krankheiten | |
DE59608738D1 (de) | Verwendung von epinastin für die behandlung von schmerzen | |
DE60031710D1 (de) | Fettsäurederivat zur behandlung von externen sekretionsstörungen | |
DE60239218D1 (de) | Synergistische zusammensetzungen für die behandlung von saatgut | |
ATE286895T1 (de) | Sulfonyl-pyrrolidinderivate geeignet für die behandlung von neurologischen krankheiten | |
ATE502642T1 (de) | Kombinationen für die behandlung von immun- entzündlichen erkrankungen | |
ATE457998T1 (de) | Abgeschwächte mikroorganismen für die behandlung von infektionen | |
DE60136477D1 (de) | Retinoide zur behandlung von emphysem | |
ATE422498T1 (de) | Tetrahydro-pyrazinoä1,2-aüindole für die behandlung von krankheiten des zentralnervensystems | |
DE60105614D1 (de) | Oxazinochinolone für die behandlung viraler infektionen | |
DE60238765D1 (de) | Carbamatverbindungen zur behandlung von schmerz | |
ATE253556T1 (de) | Aminoacylaroylpyrrole für die behandlung des neuropathischen schmerzes | |
DE60021252D1 (de) | Antikonvulsiva zur behandlung von autismus | |
ATE515266T1 (de) | 2-(amino-3,4-dioxo-1-cyclobuten-1- yl)aminoalkylsäure-derivate für die schmerzbehandlung | |
ATE527999T1 (de) | Asimadolin für die behandlung des irritable bowel syndroms | |
ATE251167T1 (de) | Oxazinocarbazole zur behandlung von cns- erkrankungen |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
UEP | Publication of translation of european patent specification |
Ref document number: 1154996 Country of ref document: EP |